Sickle Cell Disease Trial, Recruiting NCT07064174 Sponsor: University of Texas Southwestern Medical Center Condition: Sickle Cell Disease
Back to Sickle Cell Disease

Sickle Cell Disease Trial, Recruiting

NCT07064174
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older (but under 66)
  • Your kidneys are functioning at a certain minimum level, specifically an eGFR (a measure of kidney function) of 15 or above (confirm with trial site)
  • You have been diagnosed with a blood condition called a hemoglobinopathy (such as sickle cell disease or thalassemia), which will need to be confirmed by a blood or genetic test
  • People without a hemoglobinopathy may also be considered as a comparison participant, but only if their age, sex, and other personal details closely match someone already enrolled in the trial

Who may not be able to join:

  • You are 66 years old or older
  • Your kidney function is very low (eGFR below 15) or you are currently on dialysis
  • You are currently pregnant (however, you may be eligible to join 4 or more weeks after giving birth)
  • You are currently experiencing a severe sickle cell pain episode that required a hospital visit, emergency room visit, or pain clinic visit (however, you may be eligible 2 or more weeks after that episode has resolved)
  • You are currently being treated with intensive chemotherapy for an active cancer — though people on lower-level maintenance chemotherapy while in remission may still be considered (confirm with trial site)
  • You are currently incarcerated

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 214-645-8267

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
22 August 2024
Est. completion
1 December 2049

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Kidney function decline; Albuminuria

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov